Psychemedics Corporation (PMD): Price and Financial Metrics

Psychemedics Corporation (PMD): $7.51

0.22 (+3.02%)

POWR Rating

Component Grades














  • PMD scores best on the Growth dimension, with a Growth rank ahead of 0% of US stocks.
  • The strongest trend for PMD is in Stability, which has been heading down over the past 117 days.
  • PMD's current lowest rank is in the Growth metric (where it is better than 0% of US stocks).

PMD Stock Summary

  • Psychemedics Corp's market capitalization of $41,579,062 is ahead of just 7.18% of US-listed equities.
  • Over the past twelve months, PMD has reported earnings growth of -426.82%, putting it ahead of just 4.74% of US stocks in our set.
  • Revenue growth over the past 12 months for Psychemedics Corp comes in at -44.8%, a number that bests merely 7.89% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Psychemedics Corp, a group of peers worth examining would be YCBD, LBRT, MDRX, INTZ, and RNGR.
  • Visit PMD's SEC page to see the company's official filings. To visit the company's web site, go to

PMD Stock Price Chart Interactive Chart >

Price chart for PMD

PMD Price/Volume Stats

Current price $7.51 52-week high $8.36
Prev. close $7.29 52-week low $3.58
Day low $7.26 Volume 23,600
Day high $7.70 Avg. volume 32,446
50-day MA $7.01 Dividend yield N/A
200-day MA $5.82 Market Cap 41.58M

Psychemedics Corporation (PMD) Company Bio

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. The company was founded in 1985 and is based in Acton, Massachusetts.

PMD Latest News Stream

Event/Time News Detail
Loading, please wait...

PMD Latest Social Stream

Loading social stream, please wait...

View Full PMD Social Stream

Latest PMD News From Around the Web

Below are the latest news stories about Psychemedics Corp that investors may wish to consider to help them evaluate PMD as an investment opportunity.

Psychemedics Corporation Reports First Quarter 2021 Financial Results

ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2021. The Company’s revenue for the quarter ended March 31, 2021 was $5.7 million versus $7.5 million for the quarter ended March 31, 2020, a decrease of 24%. Net income for the quarter ended March 31, 2021 was $0.1 million or $0.01 per diluted share, versus net loss of $0.2 million or ($0.03) per diluted share, for the comparable period last year, an increase of $0.04 per diluted share. Raymond C. Kubacki, Chairman and Chief Executive Officer, stated: "We continued to see improvement in total revenues, month-to-month and quarter-to-quarter, since the COVID-19 shutdow...

Yahoo | May 10, 2021

Cannabis Stock Gainers And Losers From April 7, 2021

GAINERS: Cannabics Pharmaceuticals (OTC: CNBX ) shares closed up 10.92% at $0.29 MGC Pharmaceuticals (OTC: MGCLF ) shares closed up 7.78% at $0.05 Psychemedics (NASDAQ: PMD ) shares closed up 3.9% at $6.92 Invictus MD Strategies (OTC: IVITF ) shares closed up 3.66% at $0.04 Alcanna (OTC: LQSIF ) shares closed up 3.54% at $6.21 Genetic Technologies (NASDAQ: GENE ) shares closed up 3.34% at $4.33 SOL Global Investments (OTC: SOLCF ) shares closed up 3.06% at $3.70 LOSERS: Zelira Therapeutics (OTC: ZLDAF ) shares closed down 11.11% at … Full story available on

Benzinga | April 7, 2021

31 Stocks Moving in Thursday's Pre-Market Session

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA ) rose 44.4% to $10.73 in pre-market trading after the company, and EMC Pharma, announced an exclusive partnership to expand commercial channels of the Microcyn-based Rx dermatology and eye care products nationwide. AeroCentury Corp. (NYSE: ACY ) rose 38.3% to $ 4.91 in pre-market trading. The company recently reported that it filed a petition for a Chapter 11 reorganization. P&F Industries, Inc. (NASDAQ: PFIN ) shares rose 27.5% to $8.39 in pre-market trading after gaining over 9% on Wednesday. The company recently reported results for the year ended December 31, 2020. Psychemedics Corporation (NASDAQ: PMD ) rose 25.8% to $7.80 in pre-market trading. The company recently reported a Q4 loss. Jaguar Health, Inc. (NASDAQ: JAGX ) rose 17.8...

Benzinga | April 1, 2021

Cannabis Stock Gainers And Losers From March 4, 2021

GAINERS: Primo Nutraceuticals (PINK: BUGVF ) shares closed up 1.09% at $3.81 CLS Holdings USA (OTCQB: CLSH ) shares closed up 3.31% at $0.25 Psychemedics (NASDAQ: PMD ) shares closed up 2.21% at $7.18 Vireo Health Intl (OTCQX: VREOF ) shares closed up 2.15% at $3.32 LOSERS: MGC Pharmaceuticals (PINK: MGCLF ) shares closed down 20.95% at $0.05 Empower Clinics (PINK: EPWCF ) shares closed down 18.48% at $0.60 48North Cannabis (PINK: NCNNF ) shares closed down 16.71% at $0.20 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed down 15.32% at $1.88 General Cannabis (OTCQB: CANN ) shares closed down 13.64% at $0.95 Hollister Biosciences (PINK: HSTRF ) shares closed down 13.21% at $0.26 Heritage Cannabis Holding (OTCQX: HERTF ) shares closed down 12.62% at $0.13 Full story available on Benzi...

Benzinga | March 4, 2021

Cannabis Stock Gainers And Losers From January 26, 2021

GAINERS: Psychemedics (NASDAQ: PMD ) shares closed up 34.3% at $7.44 World Acceptance (NASDAQ: WRLD ) shares closed up 13.09% at $125.19 High Tide (OTCQB: HITIF ) shares closed up 11.74% at $0.53 OrganiGram Holdings (NASDAQ: OGI ) shares closed up 11.66% at $1.82 Origin Agritech (NASDAQ: SEED ) shares closed up 10.81% at $21.22 Tilray (NASDAQ: TLRY ) shares closed up 10.74% at $19.03 Cannabix Technologies (PINK: BLOZF ) shares closed up 10.57% at $1.41 EnWave (PINK: NWVCF ) shares closed up 9.49% at $1.10 cbdMd, Inc. (AMEX: YCBD) shares closed up 8.14% at $3.72 HEXO (NYSE: Full story available on

Benzinga | January 26, 2021

Read More 'PMD' Stories Here

PMD Price Returns

1-mo 12.43%
3-mo 21.72%
6-mo N/A
1-year 39.07%
3-year -55.13%
5-year -33.05%
YTD 47.54%
2020 -43.26%
2019 -38.19%
2018 -20.09%
2017 -14.14%
2016 152.68%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.949 seconds.